Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-08-04
1993-11-09
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514700, 424 10, A61K 31415, A61K 3111
Patent
active
052603270
ABSTRACT:
This invention provides methods for inhibiting the proliferation of brain or hepatic metastases, in vivo, by contacting the cells with lonidamine and radiation.
REFERENCES:
Field, J. B., et al., Cancer Res., 24(1):40-42, 57 (1964).
Kim, J. H., et al., Cancer Res., 46:1120-1123 (1986).
Kim, J. H. et al.: Clinical Study of the Sequence of Combined Hyperthermia and Radiation Therapy of Malignant Melanoma. In Hyperthermic Oncology, vol. 1, J. Overgaard (Ed.), London, Philadelphia; Taylor and Francis, 1984, pp. 387-390.
Alfieri Alan
Kim Jae H.
Kim Sang H.
Young Charles W.
Criares T. J.
Sloan-Kettering Institute for Cancer Research
Waddell Frederick E.
White John P.
LandOfFree
Methods for inhibiting the proliferation of brain and hepatic me does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for inhibiting the proliferation of brain and hepatic me, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for inhibiting the proliferation of brain and hepatic me will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1143163